spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 30 March 2004
doi: 10.1242/jcs.01051


Journal of Cell Science 117, 1979-1988 (2004)
Published by The Company of Biologists 2004
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivier, F.
Right arrow Articles by Gussoni, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivier, F.
Right arrow Articles by Gussoni, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations

François Rivier1,*,{ddagger}, Ozan Alkan2,{ddagger}, Alan F. Flint1, Kristina Muskiewicz1, Paul D. Allen3, Philippe Leboulch3 and Emanuela Gussoni1,§

1 Division of Genetics, Children's Hospital Boston, MA 02115, USA
2 Massachusetts Institute of Technology, Harvard-MIT Division of Health Sciences and Technology, 45 Carleton Street, Building E25, Room 529, Cambridge, MA 02139, USA
3 Department of Anesthesia, Brigham and Women's Hospital, Boston, MA 02115, USA



View larger version (32K):

[in a new window]
 
Fig. 1. Cell trafficking from the BM to the skeletal muscle 3 weeks after lethal irradiation and BMT. Detection via FACS analysis of donor-derived CD45.2+ cells within the MP and SP cell populations in the BM (A-D) and the skeletal muscle (E-H) of recipient females. BM cells stained with 5 µg ml-1 Hoechst in the presence (A) or absence (B) of verapamil. Over 99% of BM MP cells (C) and SP cells (D) are CD45.2+ or of donor origin. Skeletal muscle mononuclear cells stained with 12.5 µg ml-1 Hoechst dye in the presence (E) or absence (F) of verapamil. Approximately 18% of muscle MP cells (G) are CD45.2+ donor-derived, whereas all muscle SP cells are CD45.2- (H).

 


View larger version (34K):

[in a new window]
 
Fig. 2. Cell trafficking and detection of donor-derived CD45.2+ cells within the muscle MP and SP cell populations of recipient females 10 weeks (A-D) and 30 weeks (E-H) after lethal irradiation and BMT. Muscle cells were stained with 12.5 µg ml-1 Hoechst dye in the presence (A,E) or absence (B,F) of verapamil. Approximately 17% (C) and 11% (G) of muscle MP cells at 10 and 30 weeks after BMT, respectively, are CD45.2+ donor-derived. By contrast, 1% (D) and 0% (H) of muscle SP cells are CD45.2+ at 10 and 30 weeks after BMT.

 


View larger version (36K):

[in a new window]
 
Fig. 3. Analysis of host-derived CD45.1+ cells in the BM (A-C) and skeletal muscle (D-F) of MP and SP cell populations 30 weeks after BMT. As expected, very few CD45.1+ host-derived cells are detected in the MP (B) or SP population (C) of the BM after lethal irradiation and BMT, because the BM was replaced by CD45.2+ donor cells. In the skeletal muscle, host-derived CD45.1+ cells constitute 4% (E) of the MP population, whereas no host-derived CD45.1+ cells are detected within the muscle SP population (F).

 


View larger version (35K):

[in a new window]
 
Fig. 4. Phenotypical differences of muscle SP cells detected using varying Hoechst dye concentrations. Parallel samples stained with 5 µg ml-1 (A) or with 12.5 µg ml-1 (D) of Hoechst dye show different percentages of SP cells. As expected, the total percentage of CD45+ cells within the samples does not vary (B,E). However, when CD45+ cells are analyzed for Hoechst exclusion properties, 26% of CD45+ cells fall within the SP cell gate when the sample is stained with 5 µg ml-1 of Hoechst dye (C), whereas no CD45+ cells are present in the SP gate when the sample is stained with 12.5 µg ml-1 Hoechst dye (F).

 


View larger version (37K):

[in a new window]
 
Fig. 5. (A) CD45.2-PE+ BM cells purified by FACS and hybridized with the Y-chromosome probe by FISH (red). A red-orange outline at the periphery of the nuclei indicates the CD45.2-PE signal that persisted after FISH. Nuclei are counter-stained with DAPI (blue). (B) CD45.2-PE-negative muscle cells sorted by FACS and hybridized with the Y-probe by FISH. No hybridization signals were observed. (C) FACS analysis of a muscle sample, which was taken 8 weeks after BMT from a mouse injected with e-GFP plus BM. SP (2.2%) and MP (71.4%) cell gates are shown. (D) Percentage of GFP+ BM-derived cells in muscle MP cells and in muscle SP cells (E). (F) More than 98% of muscle SP cells from an e-GFP transgenic mouse are positive for e-GFP.

 


View larger version (41K):

[in a new window]
 
Fig. 6. Analysis of BM-cell trafficking to skeletal muscle MP and SP cells in the absence (A-C) or in the presence (D-F) of cardiotoxin injury (Mouse B in Table 2). FACS profiles and percentages of SP and MP cells in control (A) or cardiotoxin-injected muscles (D). Percentage of CD45.2+ donor-derived cells in muscle MP cells in the absence (B) or presence (E) of cardiotoxin injury. A near 5-fold increase of donor-derived cells is observed upon cardiotoxin injury in the MP population. Percentage of CD45.2+ donor-derived cells in muscle SP cell population in control (C) or in cardiotoxin-injured (F) muscles.

 


View larger version (44K):

[in a new window]
 
Fig. 7. Combined immunohistochemistry/FISH analysis on muscle-tissue sections of recipient female mice injected with donor male BM cells. Tissue sections were collected from samples harvested at 11 w (A), 19 w (B) and 34 w (C) after BMT. Samples (D) and (E) are muscles analyzed 18 w after transplantation and 2 w after cardiotoxin injury. (A-E) The green signal represents the expression of CD45.2 (donor-derived cells antigen). Nuclei are stained in blue by DAPI. Red dots within nuclei represent FISH hybridization using the Y-chromosome probe to confirm the donor-cell origin. (F) Immunohistochemistry using anti-CD45.2 (green) and anti-desmin (red) antibodies. A host-derived satellite cells (red) and a donor-derived CD45.2+ BM cell (green) that has migrated to the muscle are shown.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2004